Characterization of Cell Therapy Products by Flow and Laser Force Cytometry

The goal is to develop a 3 day short course (“Characterization of Cell Therapy Products by Flow and Laser Force Cytometry”) targeting multiple levels of current and future workforce.
Categories
Incumbent worker training
Project status
100% Completed

Industry Need

Traditional methods to assess infectivity, including the end-point dilution assay (TCID50) and viral plaque assay, are slow, labor intensive, and can vary depending upon the skill and experience of the user.

Solution

Provide education for the rapid detection and quantification of viral infection in the context of improving the development and production of vaccines.

Outputs/Deliverables

Development of a 3 day short course to provide the fundamentals of two cell characterization technologies (flow cytometry, laser force cytology) in relation to cell therapy (50/50 lecture/hands-on).

Impacts

This course is designed to provide the fundamentals of flow cytometry, laser force cytology in relation to cell therapy targeting multiple levels of current and future workforce.

Course content delivery in two main components: “Lectures” and “Hands-on Experiments” to facilitate advanced learning and application to cell characterization.

Publications

Additional Project Information (Members Only)

Login to the NIIMBL member portal to access more, including: 

  • Updates
  • Value Proposition
  • Related Publications
  • Deliverables

Not yet a member? Learn more about which level of NIIMBL membership is right for you and your organization.

Project Lead

Rensselaer Polytechnic Institute

Rensselaer Polytechnic Institute

Participating Organizations

Bristol-Myers Squibb

Bristol-Myers Squibb

LumaCyte

LumaCyte